- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
Biopharmaceutical company OnKure announced the appointment of Rogan Nunn as general counsel and secretary.
Nunn will report to Nicholas Saccomano, president and chief executive.
Prior to this, he served as general counsel, America at ADC Therapeutics. Before that, he served as EVP, general counsel, and secretary of Array Biopharma. Earlier, he was a corporate and M&A specialist at Skadden, Arps, Slate, Meagher & Flom.
Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
The Supreme Court of the United States overturned a long-held precedent in which courts deferred to federal agencies in interpreting complex or ambiguous regulations–a decision that could make thousands of federal regulations more vulnerable to legal challenges.
A Bank of England report warned of private equity risk management deficiencies as interest rates remain stagnant, with international coordination important.
Financial institutions would be required to conduct more thorough risk assessments on their anti-money laundering/countering the financing of terrorism programs under a new rule proposed by the Treasury Department’s Financial Crimes Enforcement Network.
No comments yet